Putting the Laboratory in the Palm of Your Hand. Detecting the presence of a disease or pathogen at the moment of contamination is critical to ensuring safety and avoiding disaster. This is the mission of SuperNova Diagnostics® and the promise of its unique AmpCrystal® technology – Any test, anywhere, any time.

Mar 28 2012
SuperNova Diagnostics® to Present at the 11th Annual Needham Healthcare Conference in New York City 
Jan 03 2012
SuperNova Diagnostics® to Present at Biotech Showcase™ 2012 during JP Morgan Healthcare Conference January 9 – 12 
Nov 22 2011
SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City 

SuperNova is leveraging its nanocrystal label technology – AmpCrystal® – and first reader system – Solaris™ – to become the leader in the $15 billion global market for point-of-care, point-of-interest™ (POC/POI) diagnostics. 

 

 

AmpCrystal® is unlike other diagnostic technologies available today.  Its powerful, cost-effective and proprietary nanobiochemistry addresses the primary shortcoming with traditional diagnostic labels – the ability to measure broad ranges of samples and also low levels of a target substance quickly and accurately without the need for amplification of sample or signal.